Nusinersen 12mg/5ml solution for injection vials
NHS hospitals in England used £49,200,000 of indicative cost of Nusinersen 12mg/5ml solution for injection vials in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is down 6.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Nusinersen 12mg/5ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Nusinersen 12mg/5ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Sheffield Teaching Hospitals Nhs Trust | £7,725,000 |
| University College London Foundation Tr | £5,400,000 |
| Leeds Teaching Hpls Nhs Trust | £3,750,000 |
| Salford Royal Nhs Foundation Trust | £3,750,000 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £2,700,000 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,625,000 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,400,000 |
| University Hospital Southampton Nhs Ft | £2,175,000 |
| University Hpls North Midlands Nhs Trust | £1,875,000 |
| Sheffield Children's Nhs Ft | £1,725,000 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.